Abstract
The purpose of this presentation is to discuss the contents of human milk from the standpoint of specific agents that might serve to protect the newborn infant from infectious disease. There are many factors in human milk for which an immunologic role has been proposed. It is necessary to assess the functions of these different factors as well as to determine whether any of these factors might be expected to survive in the infant’s digestive tract. Finally, assuming that an immunologically active agent is capable of performing its action in the newborn, it is necessary to look at the evidence as to whether an actual significant immune effect is served. This latter task can be approached only through a review of the published epidemiologic studies on breast-feeding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Seiner JC, Merrill DA, Claman HN: Salivary immunoglobulin and albumin: development during the neonatal period. J Pediatr 72: 685, 1968.
Kenny JF, Boesman MI, Michaels RH: Bacterial and viral coproantibodies in breast-fed infants. Pediatrics 39: 202, 1967.
Shim BS, Kang YS, Kim WJ, et al: Self-protective activity of colostral IgA against tryptic digestion. Nature 222: 787, 1969.
Laskowski M, Laskowski M: Crystalline trypsin inhibitor from colostrum. J Biol Chem 190: 563, 1951.
Walker WA, Isselbacher K: Uptake and transport of macromolecules by the intestine: possible role in clinical disorders. Gastroenterology 67: 531, 1974.
Mohr JA: Lymphocyte sensitization passed to the child from the mother. Lancet 1: 688, 1972.
Mohr JA: The possible induction and/or acquisition of cellular hypersensitivity associated with ingestion of colostrum. J Pediatr 82: 1062, 1972.
Pitt J: Passive transfer of milk phagocytes—mechanisms of protection in necrotizing enterocolitis in Moore TD (ed): Necrotizing Enterocolitis in the Newborn Infant, Sixty-eighth Ross Conference on Pediatric Research, Columbus, Ohio, Ross Laboratories, 1975, p 52.
Murillo GJ, Goldman AS: The cells of human colostrum II. Synthesis of IgA and Blc. Pediatr Res 4: 71, 1970.
Ballow M, Fang F, Good RA, et al: Developmental aspects of complement components and C3 proactivator (properdin factor B) in human colostrum. Clin Exp Immunol 18: 257, 1974.
Robinson M: Infant morbidity and mortality. A study of 3266 infants. Lancet 1: 788, 1951.
Sydow GV, Faxen N: Breast or cow’s milk as infant food: discussion on the methods of comparison. Acta Paediatr Scand 43: 362, 1974.
Mellander O, Vahlquist D, Mellbin T: Breast feeding and artificial feeding. A clinical, serological and biochemical study in 402 infants with a survey of the literature. The Norrbotten Study. Acta Paediatr Scand [Suppl] 48: (116): 1, 1959.
Larsen SA Jr, Homer DR: Relation of breast versus bottle feeding to hospitalization for gastroenteritis in a middle-class U.S. population. J Pediatr 92: 417, 1978.
Cunningham AS: Morbidity in breast-fed and artificially fed infants. J Pediatr 90: 726, 1977.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 John Wright · PSG Inc
About this chapter
Cite this chapter
LeLeiko, N.S. (1982). Does Human Milk Intrinsically Help Protect Newborns from Infection?. In: Vitale, J.J., Broitman, S.A. (eds) Advances in Human Clinical Nutrition. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8290-1_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-8290-1_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8292-5
Online ISBN: 978-94-009-8290-1
eBook Packages: Springer Book Archive